Xu et al. found that the YTHDC2–IGF2BP2–HNRNPC risk prognosis model has important application value in the prognosis assessment of oral cancer, which may be related to remodeling of the tumor-related immune microenvironment. This evidence concerns the gene YTHDC2 and lip and oral cavity carcinoma.